The average one-year price target for Opus Genetics (NasdaqCM:IRD) has been revised to $7.87 / share. This is an increase of 13.45% from the prior estimate of $6.94 dated November 7, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $6.06 to a high of $9.45 / share. The average price target represents an increase of 318.54% from the latest reported closing price of $1.88 / share.
What is the Fund Sentiment?
There are 62 funds or institutions reporting positions in Opus Genetics. This is an increase of 5 owner(s) or 8.77% in the last quarter. Average portfolio weight of all funds dedicated to IRD is 0.15%, an increase of 40.38%. Total shares owned by institutions increased in the last three months by 10.40% to 19,515K shares. 
The put/call ratio of IRD is 0.06, indicating a bullish outlook.
What are Other Shareholders Doing?
Perceptive Advisors holds 4,325K shares representing 6.86% ownership of the company. No change in the last quarter.
BIOS Capital Management holds 3,683K shares representing 5.84% ownership of the company. No change in the last quarter.
Nantahala Capital Management holds 3,346K shares representing 5.31% ownership of the company. No change in the last quarter.
Mink Brook Asset Management holds 1,238K shares representing 1.96% ownership of the company. In its prior filing, the firm reported owning 1,198K shares , representing an increase of 3.26%. The firm increased its portfolio allocation in IRD by 40.52% over the last quarter.
Opaleye Management holds 1,100K shares representing 1.74% ownership of the company. In its prior filing, the firm reported owning 1,220K shares , representing a decrease of 10.91%. The firm increased its portfolio allocation in IRD by 10.32% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
